PURPOSE: In this study, we estimate the impact of a recent relapse on physical and mental health in subjects with relapsing-remitting multiple sclerosis (RRMS) using validated patient-reported outcome (PRO) measures. METHODS: Subjects enrolled in the Comprehensive Longitudinal Investigation of MS at the Brigham and Women's Hospital with RRMS were eligible for enrollment. Subjects with a clinical visit within 45 days of a relapse were identified and divided into groups based on whether the relapse occurred before (recent relapse) (n = 59) or after the visit (pre-relapse) (n = 31). A group of subjects with no relapses was also identified (remission) (n = 336). PRO measures in these three groups were compared. All outcomes were compared using a t test and linear regression controlling for age, disease duration, sex, and EDSS. RESULTS: Subjects with a recent relapse had significantly worse functioning on several physical and mental health scales compared to subjects in remission even after adjusting for potential confounders. Subjects with a recent relapse also showed significant deterioration on PRO measures over 1 year compared to subjects in remission (P < 0.05 for each comparison). Subjects in the pre-relapse group were not significantly different than subjects in remission. CONCLUSIONS: Clinical relapses have a measurable effect on PRO in subjects with RRMS.
PURPOSE: In this study, we estimate the impact of a recent relapse on physical and mental health in subjects with relapsing-remitting multiple sclerosis (RRMS) using validated patient-reported outcome (PRO) measures. METHODS: Subjects enrolled in the Comprehensive Longitudinal Investigation of MS at the Brigham and Women's Hospital with RRMS were eligible for enrollment. Subjects with a clinical visit within 45 days of a relapse were identified and divided into groups based on whether the relapse occurred before (recent relapse) (n = 59) or after the visit (pre-relapse) (n = 31). A group of subjects with no relapses was also identified (remission) (n = 336). PRO measures in these three groups were compared. All outcomes were compared using a t test and linear regression controlling for age, disease duration, sex, and EDSS. RESULTS: Subjects with a recent relapse had significantly worse functioning on several physical and mental health scales compared to subjects in remission even after adjusting for potential confounders. Subjects with a recent relapse also showed significant deterioration on PRO measures over 1 year compared to subjects in remission (P < 0.05 for each comparison). Subjects in the pre-relapse group were not significantly different than subjects in remission. CONCLUSIONS: Clinical relapses have a measurable effect on PRO in subjects with RRMS.
Authors: Line E Hviid; Brian C Healy; David J Rintell; Tanuja Chitnis; Howard L Weiner; Bonnie I Glanz Journal: Mult Scler Date: 2011-03-03 Impact factor: 6.312
Authors: Sean J Pittock; William T Mayr; Robyn L McClelland; Neal W Jorgensen; Stephen D Weigand; John H Noseworthy; Moses Rodriguez Journal: Arch Neurol Date: 2004-05
Authors: Richard A Rudick; Deborah Miller; Steve Hass; Michael Hutchinson; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara Journal: Ann Neurol Date: 2007-10 Impact factor: 10.422
Authors: Martina Novotna; M Mateo Paz Soldán; Nuhad Abou Zeid; Nilufer Kale; Melih Tutuncu; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; B Mark Keegan; Istvan Pirko; Sean J Pittock; Claudia F Lucchinetti; John H Noseworthy; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci Journal: Neurology Date: 2015-07-24 Impact factor: 9.910
Authors: Kaitlynne Leclaire; Audrey Cecil; Allison LaRussa; Fiona Stuart; Christopher C Hemond; Brian C Healy; Tanuja Chitnis; Howard Weiner; Jeff Huffman; Bonnie I Glanz Journal: Int J MS Care Date: 2018 May-Jun
Authors: Amy Perrin Ross; Alona Williamson; Jennifer Smrtka; Tracy Flemming Tracy; Carol Saunders; Constance Easterling; John Niewoehner; Nicole Mutschler Journal: Mult Scler Int Date: 2013-05-26
Authors: Aaron E Miller; Richard Macdonell; Giancarlo Comi; Mark S Freedman; Ludwig Kappos; Mathias Mäurer; Tomas P Olsson; Jerry S Wolinsky; Sylvie Bozzi; Catherine Dive-Pouletty; Paul W O'Connor Journal: J Neurol Date: 2014-06-28 Impact factor: 4.849